Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Clinical trial NCT00557921 · TERMINATED

Trial details

NCT number: NCT00557921
Sponsor: Cogentus Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Coronary Syndrome Myocardial Infarction Coronary Artery Disease Percutaneous Coronary Intervention

Start date: 2007-12-01
Primary completion: 2009-11-01
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.